SP847A multicenter, open-label study to investigate the safety, tolerability, and pharmacokinetics of lacosamide (LCM) oral solution (Syrup) as adjunctive therapy in children with partial-onset seizures.
SP848An open-label extension study to determine safety, tolerability, and efficacy of long-term oral lacosamide (LCM) as adjunctive therapy in children with partial-onset seizures
A Multi-Center, Open-Label Study to Investigate the Pharmacokinetics of Commercial Lacosamide Oral Formulation as Therapy in children )age 1month to 17 years) with Epilepsy
Office of Research254 Easton Avenue
New Brunswick, NJ
(732) 745-8600 x7620
© 2013 Saint Peter’s Healthcare System254 Easton Avenue, New Brunswick, NJ 08901